Traws Pharma, Inc. Fair Value Adjustment of Warrants
Traws Pharma, Inc. (TRAW) reported Fair Value Adjustment of Warrants of -$215.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-14
- Traws Pharma, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$215.00K.
- Traws Pharma, Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was $159.00K.
- Traws Pharma, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was $89.00K.
- Traws Pharma, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $3.00K.
- Traws Pharma, Inc. fair value adjustment of warrants for fiscal 2025 was -$26.57M, a 208.71% decline from fiscal 2024.
- Traws Pharma, Inc. fair value adjustment of warrants for fiscal 2024 was $24.44M.
- Traws Pharma, Inc. fair value adjustment of warrants for fiscal 2021 was -$321.00K, a 254.33% decline from fiscal 2020.
- Traws Pharma, Inc. fair value adjustment of warrants for fiscal 2020 was $208.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$215.00K 10-Q · filed 2026-08-14 | -$56.00K 10-Q · filed 2026-08-14 | $33.00K derived: sum of 3 quarters · filed 2026-08-14 | $36.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $159.00K 10-Q · filed 2026-05-15 | $248.00K derived: sum of 2 quarters · filed 2026-05-15 | $251.00K derived: sum of 3 quarters · filed 2026-05-15 | $105.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $92.00K derived: sum of 2 quarters · filed 2026-04-15 | -$54.00K derived: sum of 3 quarters · filed 2026-08-14 | -$26.57M 10-K · filed 2026-04-15 |
| 2025-09-30 | $3.00K 10-Q · filed 2025-11-13 | -$143.00K derived: sum of 2 quarters · filed 2026-08-14 | -$26.66M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$146.00K 10-Q · filed 2026-08-14 | -$26.66M 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | -$26.51M 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $24.44M 10-K · filed 2026-04-15 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$530.00K derived: sum of 2 quarters · filed 2023-03-30 | -$957.00K derived: sum of 3 quarters · filed 2023-03-30 | -$321.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$530.00K 10-Q · filed 2022-11-14 | -$957.00K derived: sum of 2 quarters · filed 2022-11-14 | -$321.00K 10-Q · filed 2022-11-14 | -$176.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$427.00K 10-Q · filed 2022-08-15 | $209.00K 10-Q · filed 2022-08-15 | $354.00K derived: sum of 3 quarters · filed 2022-08-15 | $298.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $636.00K 10-Q · filed 2022-05-13 | $781.00K derived: sum of 2 quarters · filed 2022-05-13 | $725.00K derived: sum of 3 quarters · filed 2022-05-13 | $781.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $89.00K derived: sum of 2 quarters · filed 2022-03-21 | $145.00K derived: sum of 3 quarters · filed 2022-03-21 | $208.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | -$56.00K 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $63.00K 10-Q · filed 2021-11-15 | $80.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $56.00K 10-Q · filed 2021-08-16 | $119.00K 10-Q · filed 2021-08-16 | $136.00K derived: sum of 3 quarters · filed 2021-08-16 | -$340.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $63.00K 10-Q · filed 2021-05-17 | $80.00K derived: sum of 2 quarters · filed 2021-05-17 | -$396.00K derived: sum of 3 quarters · filed 2021-05-17 | -$428.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$459.00K derived: sum of 2 quarters · filed 2021-03-18 | -$491.00K derived: sum of 3 quarters · filed 2021-03-18 | -$63.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | -$476.00K 10-Q · filed 2020-11-16 | -$508.00K derived: sum of 2 quarters · filed 2020-11-16 | -$80.00K 10-Q · filed 2020-11-16 | -$224.00K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$32.00K 10-Q · filed 2020-08-12 | $395.00K 10-Q · filed 2020-08-12 | $252.00K derived: sum of 3 quarters · filed 2020-08-12 | $123.00K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $427.00K 10-Q · filed 2020-05-15 | $284.00K derived: sum of 2 quarters · filed 2020-05-15 | $155.00K derived: sum of 3 quarters · filed 2020-05-15 | -$358.00K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | -$143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$272.00K derived: sum of 2 quarters · filed 2020-03-27 | -$785.00K derived: sum of 3 quarters · filed 2020-03-27 | -$1.60M 10-K · filed 2020-03-27 |
| 2018-09-30 | -$129.00K 10-Q · filed 2019-11-12 | -$642.00K derived: sum of 2 quarters · filed 2019-11-12 | -$1.45M 10-Q · filed 2019-11-12 | -$1.37M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$513.00K 10-Q · filed 2019-08-14 | -$1.32M 10-Q · filed 2019-08-14 | -$1.24M derived: sum of 3 quarters · filed 2019-08-14 | -$1.03M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$812.00K 10-Q · filed 2019-05-15 | -$724.00K derived: sum of 2 quarters · filed 2019-05-15 | -$514.00K derived: sum of 3 quarters · filed 2019-05-15 | -$3.99M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $298.00K derived: sum of 2 quarters · filed 2019-04-01 | -$3.18M derived: sum of 3 quarters · filed 2019-04-01 | -$1.63M 10-K · filed 2019-04-01 |
| 2017-09-30 | $210.00K 10-Q · filed 2018-11-14 | -$3.26M derived: sum of 2 quarters · filed 2018-11-14 | -$1.72M 10-Q · filed 2018-11-14 | -$2.72M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | -$3.47M 10-Q · filed 2018-08-14 | -$1.93M 10-Q · filed 2018-08-14 | -$2.93M derived: sum of 3 quarters · filed 2018-08-14 | -$5.63M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $1.55M 10-Q · filed 2018-05-15 | $546.00K derived: sum of 2 quarters · filed 2018-05-15 | -$2.16M derived: sum of 3 quarters · filed 2018-05-15 | -$2.17M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$3.71M derived: sum of 2 quarters · filed 2018-03-16 | -$3.72M derived: sum of 3 quarters · filed 2018-03-16 | -$3.99M 10-K · filed 2018-03-16 |
| 2016-09-30 | -$2.71M 10-Q · filed 2017-11-09 | -$2.71M derived: sum of 2 quarters · filed 2017-11-09 | -$2.98M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | -$8.00K 10-Q · filed 2017-08-14 | -$279.00K 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | -$271.00K 10-Q · filed 2017-05-15 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | -$1.00K derived: sum of 2 quarters · filed 2016-03-28 | -$4.00K derived: sum of 3 quarters · filed 2016-03-28 | -$20.00K 10-K · filed 2016-03-28 |
| 2014-09-30 | -$1.00K 10-Q · filed 2015-11-12 | -$4.00K derived: sum of 2 quarters · filed 2015-11-12 | -$20.00K 10-Q · filed 2015-11-12 | -$81.00K derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | -$3.00K 10-Q · filed 2015-08-13 | -$19.00K 10-Q · filed 2015-08-13 | -$80.00K derived: sum of 3 quarters · filed 2015-08-13 | -$49.00K derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | -$16.00K 10-Q · filed 2015-05-15 | -$77.00K derived: sum of 2 quarters · filed 2015-05-15 | -$46.00K derived: sum of 3 quarters · filed 2015-05-15 | -$44.00K derived: sum of 4 quarters · filed 2015-05-15 |
| 2013-12-31 | -$61.00K 10-K · filed 2015-03-30 | -$30.00K derived: sum of 2 quarters · filed 2015-03-30 | -$28.00K derived: sum of 3 quarters · filed 2015-03-30 | -$42.00K 10-K · filed 2015-03-30 |
| 2013-09-30 | $31.00K 10-K · filed 2015-03-30 | $33.00K derived: sum of 2 quarters · filed 2015-03-30 | $19.00K 10-Q · filed 2014-11-14 | $17.00K derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-06-30 | $2.00K 10-K · filed 2015-03-30 | -$12.00K 10-Q · filed 2014-08-14 | -$14.00K derived: sum of 3 quarters · filed 2015-03-30 | $11.00K derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-03-31 | -$14.00K 10-K · filed 2015-03-30 | -$16.00K derived: sum of 2 quarters · filed 2015-03-30 | $9.00K derived: sum of 3 quarters · filed 2015-03-30 | -$990.00K derived: sum of 4 quarters · filed 2015-03-30 |
| 2012-12-31 | -$2.00K 10-K · filed 2014-03-20 | $23.00K derived: sum of 2 quarters · filed 2014-03-20 | -$976.00K derived: sum of 3 quarters · filed 2014-03-20 | -$367.00K 10-K · filed 2015-03-30 |
| 2012-09-30 | $25.00K 10-K · filed 2014-03-20 | -$974.00K derived: sum of 2 quarters · filed 2014-03-20 | -$365.00K 10-Q · filed 2013-11-14 | |
| 2012-06-30 | -$999.00K 10-K · filed 2014-03-20 | -$390.00K 10-Q · filed 2013-09-06 | ||
| 2012-03-31 | $609.00K 10-K · filed 2014-03-20 | |||
| 2011-12-31 | -$1.29M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |